Maintenance therapy with low-dose azacitidine after allogeneic hematopoietic stem cell transplantation for recurrent acute myelogenous leukemia or myelodysplastic syndrome
Тип публикации: Journal Article
Дата публикации: 2010-07-29
scimago Q1
wos Q1
БС1
SJR: 2.947
CiteScore: 11.5
Impact factor: 5.1
ISSN: 0008543X, 10970142
PubMed ID:
20672358
Краткое описание
Recurrence is a major cause of treatment failure after allogeneic transplantation for acute myelogenous leukemia (AML) and myelodysplastic syndrome (MDS), and treatment options are very limited. Azacitidine is a DNA methyltransferase inhibitor with activity in myeloid disease. The authors hypothesized that low‐dose azacitidine administered after transplant would reduce recurrence rates, and conducted a study to determine a safe dose/schedule combination.
Найдено
Ничего не найдено, попробуйте изменить настройки фильтра.
Топ-30
Журналы
|
5
10
15
20
25
30
35
40
45
50
|
|
|
Biology of Blood and Marrow Transplantation
46 публикаций, 11.73%
|
|
|
Bone Marrow Transplantation
25 публикаций, 6.38%
|
|
|
American Journal of Hematology
19 публикаций, 4.85%
|
|
|
Current Opinion in Hematology
14 публикаций, 3.57%
|
|
|
Blood
11 публикаций, 2.81%
|
|
|
Transplantation and Cellular Therapy
10 публикаций, 2.55%
|
|
|
Clinical Lymphoma, Myeloma and Leukemia
9 публикаций, 2.3%
|
|
|
Leukemia and Lymphoma
9 публикаций, 2.3%
|
|
|
Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program
9 публикаций, 2.3%
|
|
|
Annals of Hematology
8 публикаций, 2.04%
|
|
|
Expert Review of Hematology
8 публикаций, 2.04%
|
|
|
Cancers
7 публикаций, 1.79%
|
|
|
Frontiers in Oncology
7 публикаций, 1.79%
|
|
|
International Journal of Hematology
7 публикаций, 1.79%
|
|
|
Leukemia
6 публикаций, 1.53%
|
|
|
Best Practice and Research in Clinical Haematology
6 публикаций, 1.53%
|
|
|
Blood advances
6 публикаций, 1.53%
|
|
|
Current Hematologic Malignancy Reports
5 публикаций, 1.28%
|
|
|
Therapeutic Advances in Hematology
4 публикации, 1.02%
|
|
|
Journal of Clinical Medicine
4 публикации, 1.02%
|
|
|
Blood Reviews
4 публикации, 1.02%
|
|
|
Cancer
4 публикации, 1.02%
|
|
|
Statistics in Medicine
4 публикации, 1.02%
|
|
|
Journal of Clinical Oncology
4 публикации, 1.02%
|
|
|
Future Oncology
3 публикации, 0.77%
|
|
|
International Journal of Hematologic Oncology
3 публикации, 0.77%
|
|
|
Current Opinion in Oncology
3 публикации, 0.77%
|
|
|
Journal of Hematology and Oncology
3 публикации, 0.77%
|
|
|
European Journal of Haematology
3 публикации, 0.77%
|
|
|
5
10
15
20
25
30
35
40
45
50
|
Издатели
|
20
40
60
80
100
120
|
|
|
Elsevier
106 публикаций, 27.04%
|
|
|
Springer Nature
72 публикации, 18.37%
|
|
|
Wiley
49 публикаций, 12.5%
|
|
|
Taylor & Francis
35 публикаций, 8.93%
|
|
|
American Society of Hematology
26 публикаций, 6.63%
|
|
|
Ovid Technologies (Wolters Kluwer Health)
20 публикаций, 5.1%
|
|
|
MDPI
17 публикаций, 4.34%
|
|
|
Frontiers Media S.A.
12 публикаций, 3.06%
|
|
|
American Society of Clinical Oncology (ASCO)
7 публикаций, 1.79%
|
|
|
SAGE
5 публикаций, 1.28%
|
|
|
Practical Medicine Publishing House
3 публикации, 0.77%
|
|
|
S. Karger AG
2 публикации, 0.51%
|
|
|
BMJ
2 публикации, 0.51%
|
|
|
Hindawi Limited
2 публикации, 0.51%
|
|
|
Cambridge University Press
2 публикации, 0.51%
|
|
|
AME Publishing Company
2 публикации, 0.51%
|
|
|
Research Square Platform LLC
2 публикации, 0.51%
|
|
|
National Medical Research Center of Hematology of the Ministry of Health of the Russian Federation
1 публикация, 0.26%
|
|
|
Massachusetts Medical Society
1 публикация, 0.26%
|
|
|
The American Association of Immunologists
1 публикация, 0.26%
|
|
|
F1000 Research
1 публикация, 0.26%
|
|
|
IOS Press
1 публикация, 0.26%
|
|
|
Spandidos Publications
1 публикация, 0.26%
|
|
|
Japanese Society of Internal Medicine
1 публикация, 0.26%
|
|
|
Huazhong University of Science and Technology
1 публикация, 0.26%
|
|
|
OMICS Publishing Group
1 публикация, 0.26%
|
|
|
Georg Thieme Verlag KG
1 публикация, 0.26%
|
|
|
Walter de Gruyter
1 публикация, 0.26%
|
|
|
Ferrata Storti Foundation
1 публикация, 0.26%
|
|
|
20
40
60
80
100
120
|
- Мы не учитываем публикации, у которых нет DOI.
- Статистика публикаций обновляется еженедельно.
Вы ученый?
Создайте профиль, чтобы получать персональные рекомендации коллег, конференций и новых статей.
Метрики
392
Всего цитирований:
392
Цитирований c 2025:
11
(2.81%)
Цитировать
ГОСТ |
RIS |
BibTex |
MLA
Цитировать
ГОСТ
Скопировать
de Lima M. et al. Maintenance therapy with low-dose azacitidine after allogeneic hematopoietic stem cell transplantation for recurrent acute myelogenous leukemia or myelodysplastic syndrome // Cancer. 2010. Vol. 116. No. 23. pp. 5420-5431.
ГОСТ со всеми авторами (до 50)
Скопировать
de Lima M., Giralt S., Thall P. F., De Padua Silva L., Jones R. B., Krishna K., Braun T. M., Nguyen H. Q., Champlin R., Garcia-Manero G. Maintenance therapy with low-dose azacitidine after allogeneic hematopoietic stem cell transplantation for recurrent acute myelogenous leukemia or myelodysplastic syndrome // Cancer. 2010. Vol. 116. No. 23. pp. 5420-5431.
Цитировать
RIS
Скопировать
TY - JOUR
DO - 10.1002/cncr.25500
UR - https://doi.org/10.1002/cncr.25500
TI - Maintenance therapy with low-dose azacitidine after allogeneic hematopoietic stem cell transplantation for recurrent acute myelogenous leukemia or myelodysplastic syndrome
T2 - Cancer
AU - de Lima, Marcos
AU - Giralt, Sergio
AU - Thall, Peter F.
AU - De Padua Silva, Leandro
AU - Jones, Roy B.
AU - Krishna, Komanduri
AU - Braun, Thomas M.
AU - Nguyen, Hoang Q
AU - Champlin, Richard
AU - Garcia-Manero, Guillermo
PY - 2010
DA - 2010/07/29
PB - Wiley
SP - 5420-5431
IS - 23
VL - 116
PMID - 20672358
SN - 0008-543X
SN - 1097-0142
ER -
Цитировать
BibTex (до 50 авторов)
Скопировать
@article{2010_de Lima,
author = {Marcos de Lima and Sergio Giralt and Peter F. Thall and Leandro De Padua Silva and Roy B. Jones and Komanduri Krishna and Thomas M. Braun and Hoang Q Nguyen and Richard Champlin and Guillermo Garcia-Manero},
title = {Maintenance therapy with low-dose azacitidine after allogeneic hematopoietic stem cell transplantation for recurrent acute myelogenous leukemia or myelodysplastic syndrome},
journal = {Cancer},
year = {2010},
volume = {116},
publisher = {Wiley},
month = {jul},
url = {https://doi.org/10.1002/cncr.25500},
number = {23},
pages = {5420--5431},
doi = {10.1002/cncr.25500}
}
Цитировать
MLA
Скопировать
de Lima, Marcos, et al. “Maintenance therapy with low-dose azacitidine after allogeneic hematopoietic stem cell transplantation for recurrent acute myelogenous leukemia or myelodysplastic syndrome.” Cancer, vol. 116, no. 23, Jul. 2010, pp. 5420-5431. https://doi.org/10.1002/cncr.25500.